Biosynex Stock
Stocks
ALBIO
FR0011005933
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Euronext Paris
23:55:00 04/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 0.8920 EUR | +1.13% |
|
-0.89% | +49.66% |
| 09-05 | Biosynex: creditors to vote on financial safeguard plan |  |
| 08-07 | Biosynex hit by cyberattack, operational activity remains intact | |
| Market Cap | 16.44M 19.11M 15.47M 14.13M 26.43M 1.8B 26.51M 183M 70.93M 926M 71.75M 70.18M 2.98B | P/E 2024 |
-0.43x | P/E 2025 | -0.19x |
|---|---|---|---|---|---|
| Enterprise Value | 69.63M 80.92M 65.51M 59.85M 112M 7.64B 112M 774M 300M 3.92B 304M 297M 12.63B | EV / Sales 2024 |
0.71x | EV / Sales 2025 | 0.68x |
| Free-Float |
40.35% | Yield 2024 * |
-
| Yield 2025 | - |
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| ALBIO | Real-time | |
Deutsche Boerse AG
| 0DL | Delayed | |
|
Börse Stuttgart
| 0DL | Delayed | |
|
Boerse Muenchen
| 0DL | Real-time | |
|
CBOE
| Real-time | ||
|
CBOE
| Real-time |
| 1 day | +1.13% | ||
| 1 week | -0.89% | ||
| Current month | -0.67% | ||
| 1 month | -1.98% | ||
| 3 months | -1.98% | ||
| 6 months | +2.53% | ||
| Current year | +49.66% |
| 1 week | 0.81 |  | 0.92 |
| 1 month | 0.81 | | 1 |
| Current year | 0.56 | | 1.57 |
| 1 year | 0.46 | | 1.57 |
| 3 years | 0.46 | | 10.9 |
| 5 years | 0.46 | | 28.78 |
| 10 years | 0.46 | | 30.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
Larry Abensur
CEO | Chief Executive Officer | 71 | 24/06/2015 |
Thierry Paper
CTO | Chief Tech/Sci/R&D Officer | 63 | 01/01/2015 |
Oren Bitton
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Thierry Paper
BRD | Director/Board Member | 63 | 24/06/2015 |
Thomas Lamy
BRD | Director/Board Member | - | 24/06/2015 |
Larry Abensur
CHM | Chairman | 71 | 24/06/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 15/2/23 | Buy | Director | 2,500 | 0.0244% | ||
| 15/2/23 | Buy | Director | 2,500 | 0.0244% | ||
| 28/2/22 | Buy | Chief Executive Officer | 2,000 | 0.0180% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.13% | -0.89% | -25.04% | -91.74% | 19.11M | |
| +0.23% | -0.06% | +163.05% | +361.04% | 21.66B | |
| -2.24% | -1.33% | -35.83% | -22.38% | 10.16B | |
| -0.90% | +1.80% | +361.68% | +15.91% | 8.16B | |
| -0.99% | -2.18% | -31.03% | - | 7.08B | |
| -0.01% | +0.20% | +87.61% | +50.03% | 6.59B | |
| +2.34% | -1.27% | -20.56% | -16.40% | 6.03B | |
| -1.82% | -1.64% | -8.72% | -21.79% | 4.33B | |
| -0.62% | -0.38% | +76.78% | +83.40% | 4.22B | |
| +1.82% | -0.27% | -18.22% | -29.00% | 2.81B | |
| Average | -0.11% | -0.47% | +54.97% | +36.56% | 7.11B | |
| Weighted average by Cap. | -0.33% | -0.26% | +92.71% | +127.04% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 101M 118M 95.18M 86.95M 163M 11.1B 163M 1.12B 436M 5.7B 441M 432M 18.35B | 95.19M 111M 89.56M 81.82M 153M 10.44B 153M 1.06B 411M 5.36B 415M 406M 17.26B |
| Net income | -43.33M -50.36M -40.77M -37.24M -69.67M -4.75B -69.86M -482M -187M -2.44B -189M -185M -7.86B | -58.22M -67.66M -54.78M -50.04M -93.61M -6.39B -93.87M -647M -251M -3.28B -254M -249M -10.56B |
| Net Debt | 52.94M 61.52M 49.81M 45.5M 85.11M 5.81B 85.34M 589M 228M 2.98B 231M 226M 9.6B | 53.19M 61.81M 50.04M 45.72M 85.52M 5.84B 85.75M 591M 229M 2.99B 232M 227M 9.65B |
Employees
397
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | €0.8920 | +1.13% | 1,246 |
| 03/09/26 | €0.8820 | +0.23% | 2,792 |
| 02/09/26 | €0.8800 | -1.57% | 19,500 |
| 01/09/26 | €0.8940 | -0.45% | 6,413 |
| 31/08/26 | €0.8980 | -0.22% | 2,129 |
- Stock Market
- Stocks
- ALBIO Stock
Select your edition
All financial news and data tailored to specific country editions
